Amgen Inc AMGN:NASDAQ

Last Price$200.80NASDAQ Previous Close - Last Trade as of 4:00PM ET 10/11/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$199.00 (3)
Ask (Size)$200.77 (2)
Day Low / HighN/A - N/A
Volume2.5 M
 

View Biotechnology IndustryPeer Comparison as of 10/11/2019

 

Amgen Inc ( NASDAQ )

Price: $200.80
Change: +2.12 (1.07%)
Volume: 2.5 M
4:00PM ET 10/11/2019
 
 

Gilead Sciences Inc ( NASDAQ )

Price: $63.99
Change: +0.73 (1.15%)
Volume: 5.7 M
4:00PM ET 10/11/2019
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Celgene Corp ( NASDAQ )

Price: $100.57
Change: +0.76 (0.76%)
Volume: 3.7 M
4:00PM ET 10/11/2019
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

Sector Update: Health Care Majors Trade Higher Pre-Bell Friday
9:20AM ET 10/11/2019 MT Newswires

Top Health Care Stocks: JNJ: +1.41% PFE: +1.12% ABT: +0.35% MRK: +0.41% AMGN: +0.16% Health care majors were trading higher pre-bell Friday. Early movers...

Sector Update: Health Care Giants Mixed Pre-Bell Thursday
9:14AM ET 10/10/2019 MT Newswires

Top Health Care Stocks: JNJ: -0.55% PFE: +0.14% ABT: -0.01% MRK: -0.53% AMGN: Flat Health care giants were mixed pre-bell Thursday. Stocks moving on news...

Sector Update: Health Care Heavyweights Mixed Pre-Bell Wednesday
9:15AM ET 10/09/2019 MT Newswires

Top Health Care Stocks: JNJ: -1.02% PFE: +0.34% ABT: Flat MRK: +0.50% AMGN: Flat Health care heavyweights were mixed pre-bell Wednesday. Stocks moving on...

Sector Update: Leading Health Care Stocks Mostly Lower Pre-Bell Tuesday
9:17AM ET 10/08/2019 MT Newswires

Top Health Care Stocks: JNJ: Flat PFE: -0.36% ABT: -0.79% MRK: -0.10% AMGN: Flat Leading health care stocks were mostly lower pre-bell Tuesday. Early...

View all Commentary and Analysis

Top Research Reports for Toyota, Amgen & TJX
11:29AM ET 10/11/2019 Zacks

Top Research Reports for Toyota, Amgen & TJX

Amgen's Latest Data With KRAS G12C Inhibitor Drug Is Mixed, But Can Still Shine On Prior Evidence
12:10PM ET 10/10/2019 Seeking Alpha

Monthly Review Of DivGro: September 2019
7:06AM ET 10/10/2019 Seeking Alpha

The R.I.P. Portfolio's Q3 2019 Update
12:30PM ET 10/08/2019 Seeking Alpha

Company Profile

Business DescriptionAmgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA. View company web site for more details
AddressOne Amgen Center Drive
Thousand Oaks, California 91320-1799
Phone+1.805.447.1000
Number of Employees21,500
Recent SEC Filing10/03/20194
Chairman & Chief Executive OfficerRobert A. Bradway
Executive Vice President-OperationsEsteban Santos
Chief Financial Officer & Executive Vice PresidentDavid W. Meline
Chief Information Officer & Senior Vice PresidentMike Zahigian

Company Highlights

Price Open$200.23
Previous Close$198.68
52 Week Range$166.30 - 211.90
Market Capitalization$120.4 B
Shares Outstanding599.7 M
SectorHealth Technology
IndustryBiotechnology
Current Dividend / Yield$1.45 / 2.89%
Dividend Ex-Date08/14/2019
Dividend Pay-Date09/06/2019
Dividend Yield 5 Year AverageN/A
Next Earnings Announcement10/29/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings15.91
Earnings per Share$12.63
Beta vs. S&P 500N/A
Revenue$23.8 B
Net Profit Margin33.87%
Return on Equity65.67%

Analyst Ratings as of 10/10/2019

Buy
9
Overweight
1
Hold
13
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset